GHRH 1-29

Description

GHRH 1-29 Overview

GHRH 1-29 is an investigational synthetic peptide corresponding to the first 29 amino acids of growth hormone-releasing hormone (GHRH). This fragment, commonly referred to as GHRH(1-29), represents the biologically active portion of the endogenous hormone responsible for initiating signaling at the growth hormone-releasing hormone receptor (GHRHR).

Within laboratory environments, GHRH 1-29 is frequently utilized in experimental endocrinology and molecular signaling research to investigate receptor-mediated peptide signaling and endocrine regulatory pathways. Because it mimics the N-terminal active region of endogenous GHRH, the peptide serves as a research tool for studying G-protein-coupled receptor (GPCR) activation, intracellular signaling cascades, and peptide-receptor interactions.

Chemical and Molecular Properties

Peptide Name	GHRH 1-29
Peptide Class	Synthetic peptide hormone fragment
Amino Acid Length	29 amino acids
Molecular Formula	C149H246N44O42S
Molecular Weight	~3357.9 g/mol
Structural Type	Linear polypeptide
Parent Molecule	Growth Hormone-Releasing Hormone (GHRH)

Working Mechanism of GHRH 1-29

Interaction with Growth Hormon-Releasing Hormone Receptor

In experimental models, GHRH 1-29 functions as a ligand for the growth hormone–releasing hormone receptor (GHRHR), a G-protein-coupled receptor (GPCR) located on endocrine cell membranes.

Binding of the peptide to GHRHR in in vitro receptor-binding studies initiates conformational changes within the receptor structure. These changes facilitate activation of Gs-type heterotrimeric G proteins, which subsequently stimulate intracellular signaling cascades.

Activation of the cAMP Signaling Pathway

Following receptor activation in experimental systems, intracellular signaling typically involves the adenylyl cyclase-cyclic AMP (cAMP) pathway. Activation of this pathway results in:

• Increased adenylyl cyclase activity
  
• Elevation of intracellular cAMP concentrations
  
• Activation of protein kinase A (PKA)

These molecular events are widely studied in cell culture research models to analyze peptide-mediated signal transduction processes.

Downstream Transcriptional Signaling

In experimental cellular systems, activation of the PKA signaling pathway may influence transcriptional regulatory proteins such as cAMP response element-binding protein (CREB). Phosphorylation of CREB in laboratory models can modify transcriptional activity associated with endocrine signaling pathways.

Such mechanisms are commonly investigated using molecular biology techniques including reporter gene assays, transcription factor analysis, and intracellular signaling studies.

Receptor Desensitization and Signal Regulation

Like many GPCR ligands, GHRH 1-29 may also participate in receptor regulatory processes observed in experimental systems, including:

• Receptor internalization
  
• B-arrestin recruitment
  
• Signal attenuation following sustained receptor activation

These regulatory mechanisms are often studied in cell-based receptor pharmacology experiments designed to evaluate peptide-receptor signaling dynamics.

Research Applications of GHRH 1-29 in Laboratory Settings

Peptide-Receptor Interaction Studies

GHRH 1-29 is frequently used in biochemical and receptor-binding experiments investigating the structural and functional properties of growth hormone-releasing hormone receptors. Experimental applications may include:

• Ligand-receptor binding assays
  
• Receptor affinity and kinetics analysis
  
• Structural modeling of peptide-GPCR interactions

These studies contribute to the broader understanding of peptide hormone receptor pharmacology.

Intracellular Signaling Research

The peptide is also used in cell-based experimental models designed to analyze intracellular signaling mechanisms associated with GPCR activation. Such studies commonly investigate:

• cAMP signaling pathways
  
• Protein kinase activation cascades
  
• Transcription factor regulation in endocrine signaling networks

These experiments typically employ cultured endocrine cell lines and molecular signaling assays.

Endocrine System Research Models

In preclinical research settings, GHRH 1-29 serves as a tool compound for examining regulatory pathways associated with endocrine peptide signaling. Experimental frameworks may explore:

• Molecular regulation of endocrine signaling networks
  
• Signal transduction processes involving peptide hormones
  
• Receptor-mediated communication within endocrine cell systems

Structural and Peptide Chemistry Research

GHRH 1-29 is also utilized in peptide chemistry and structural biology studies. Researchers may investigate:

• Structure-activity relationships of GHRH peptide fragments
  
• Peptide stability and conformational dynamics
  
• Interaction of peptide ligands with GPCR extracellular domains

Laboratory methods frequently include mass spectrometry, peptide synthesis analysis, and molecular docking simulations.

Why Choose Purerawz for GHRH 1-29?

Buy GHRH 1-29 for laboratory research use from our online shop. At Purerawz, we provide high-quality reference materials. Each research compound comes with a Certificate of Analysis for verification of purity and concentration.

Disclaimer

This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

Reference Links

• Prakash, A., & Goa, K. L. (1999). GHRH 1-29. BioDrugs, 12(2), 139-157. https://doi.org/10.2165/00063030-199912020-00007